NCT07060989
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07060989
Title A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (NTS071)
Acronym NTS071
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Nutshell Therapeutics (Shanghai) Co., LTD.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale Cancer Center RECRUITING New Haven Connecticut 200031 United States Details
University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 200031 United States Details
Peking University People's Hospital RECRUITING Beijing 100044 China Details
Beijing Cancer Hospital RECRUITING Beijing 100142 China Details
Guangdong Provincial People's Hospital NOT_YET_RECRUITING Guangzhou 510120 China Details
The First Affiliated Hospital of Nanchang University - Xianghu District RECRUITING Nanchang 330019 China Details
Fudan University Shanghai Cancer Center RECRUITING Shanghai 200032 China Details
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine RECRUITING Shanghai 200127 China Details
The First Affiliated Hospital of Xi'an Jiaotong University RECRUITING Xi'an 710061 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field